<?xml version="1.0" encoding="UTF-8"?>
<p>In total, 109/701 (15.54%) in the male group and 101/605 (16.69%) in the female group were positive for anti-IgM CHIKV antibodies and 33/701 (4.07%) in the male group and 49/605 (8.09%) in the female group were positive for anti-IgM DENV antibodies.</p>
